Condensed Consolidated Statement of Comprehensive Income

Continuing operations

Revenue from contracts with customers

(2.6)

4 211 131

4 322 875

4 195 378

Dividends received

143

–

–

Fair value gains

–

1 769

380

Finance income

17 955

16 044

21 823

Other income

130

–

3 052

Compensation for impairment of property and equipment

–

–

64 402

Insurance revenue

67 705

69 975

51 058

Insurance service expense

(60 719)

(65 651)

(50 747)

Insurance finance income

3 557

4 905

3 300

Cost of pharmaceutical products and finished goods

19.4

(830 432)

(1 030 844)

(878 351)

Cost of distribution of pharmaceutical products

(29 811)

(37 691)

(38 329)

Employee benefit costs

(4.3)

(1 427 683)

(1 368 788)

(1 385 701)

Other expenses

14.0

(426 428)

(495 790)

(425 437)

Capitation funds

(2.0)

(856 684)

(840 010)

(878 805)

Amortisation (Note 1)

(108 689)

(97 695)

(104 642)

Rent and property costs

(60 086)

(63 750)

(68 155)

Right-of-use asset depreciation

(32 287)

(19 197)

(31 282)

Depreciation

(62 337)

(48 839)

(55 884)

IT costs

(201 305)

(88 898)

(199 815)

Write-off of intangible assets

(9 421)

(6 060)

(3 792)

Impairment of goodwill

–

(230 835)

(218 000)

Impairment of other financial assets

–

(826)

(7 210)

Write-off of other financial assets

–

–

(1 184)

Impairment of investment in associates

–

(14 661)

(274)

Impairment of property and equipment

–

(26 611)

–

Impairment of loans

–

(1 266)

–

Reversal of impairment of loans

33

–

–

Share of profits/(losses) from associates and joint ventures

2 600

(11 550)

(2 199)

Interest on lease liabilities

(7 278)

(10 697)

(8 017)

Finance costs

(29 083)

(37 075)

(32 298)

Income tax expense

(9.3)

(52 914)

(48 403)

(62 786)

Owners of the parent

101 036

(137 733)

(120 579)

Non-controlling interests

7 061

8 164

7 064

Discontinued Operations

(Loss)/profit from discontinued operations net of tax (Note 7)

(6 544)

18 848

(5 639)

Profit on sale of subsidiary (Note 5)

5 101

–

–

Owners of the parent

(3 972)

19 353

(5 286)

Non-controlling interests

2 529

(505)

(353)

Profit/(loss) for the period attributable to:

Owners of the parent

97 064

(118 380)

(125 865)

Non-controlling interests

9 590

7 659

6 711

Other comprehensive income

Components of other comprehensive loss that will not be reclassified to profit or loss

Total other comprehensive loss that will not be reclassified to profit or loss

–

(52)

(43)

Remeasurement of post-employment benefit obligations

Income tax relating to these items

Components of other comprehensive (loss)/income that will be reclassified to profit or loss

Foreign exchange (loss)/gain

Comprehensive income/(loss) attributable to:

Comprehensive income/(loss) attributable to owners of parent

91 518

(126 812)

(116 353)

Comprehensive income attributable to non-controlling interests

9 590

7 659

6 711